mobile.zenopa.com Homepage Homepage
Employment Role Location
Business Sector Advanced  
Phone 01494 818 000
Current Jobs

Territory Manager - UCC
Location: Bucks, Essex

HCP Representative
Location: London

Territory Manager - Sports Medicine
Location: Devon and Cornwall

Urology Sales Specialist
Location: West Midlands

Senior Brand Manager (Maternity Cover)
Location: Cambridge

Sales Specialist
Location: London

Global Planning Partner
Location: London

Skin Health Sales Representative
Location: Peterborough, Cambs, Northants

Territory Manager - Sports Medicine
Location: Western Ireland

Senior Business Unit Manager
Location: Berkshire

Senior Account Executive
Location: Kent

HCP Representative
Location: Scotland

Nurse Advisor
Location: Scottish Highlands

Nurse Advisor
Location: Forth Valley

Sales Specialist - PAS
Location: South East

Report claims 'postcode lottery' in cancer treatment

Posted on 13/08/2008 in Medical Government/ NHS related news

New research from the Rarer Cancers Forum (RCF) claims a "postcode lottery" exists for those making an exceptional request for cancer treatment on the NHS.

In its audit of the policies and methods used by primary care trusts (PCTs) to assess exceptional funding requests, the forum found 5,000 patients were forced to demonstrate their exceptionality, with 1,300 having their requests rejected.

The paper found national variations in these decisions, with some areas approving all requests and some approving none.

Furthermore, the RCF claimed there existed a lack of understanding among PCTs of the rules in these cases and of government policy to make decision-making in this area more transparent.

"National guidance should be published informing PCTs how they should process exceptional cases, so that there is greater consistency across the country," the forum said.

It added targets should be set to speed up the processing of applications, while National Institute of Clinical Health and Excellence guidelines should be altered so fewer patients should have to make exceptional funding requests.

In response to this research, Macmillan Cancer Support said the RCF was correct to highlight the difficulties faced by cancer patients when their treatment is denied by their PCT.

Other news stories from 13/08/2008

Read more in the Zenopa News Archive

How this news is generated

Joe
Operations Director
01494 818 011
(Mon to Fri 0830 to 1800 hours)
joe@zenopa.com

Pharmaceutical Sales Jobs | Pharmaceutical Executive Jobs | Pharmaceutical Marketing Jobs | Medical Sales Jobs | Medical Devices Marketing Jobs | Medical Executive Jobs
Dental Sales Jobs | Veterinary Sales Jobs | Scientific Sales Jobs | Consumer Healthcare Sales Jobs | Consumer Healthcare Management Jobs | Medical Writing Jobs
Medical Writer Jobs | Healthcare PR Jobs | Animal Health Sales Jobs

home | our clients | browse news | browse jobs | links | hotel directory | Valid HTML | copyright © 2012 Zenopa Ltd | terms & conditions of use